Publications by authors named "Michael Buchert"

27Publications

IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers?

Front Immunol 2020 3;11:1389. Epub 2020 Jul 3.

Olivia Newton-John Cancer Research Institute, and La Trobe University School of Cancer Medicine, Heidelberg, VIC, Australia.

View Article and Find Full Text PDF
July 2020

The JAK/STAT3 axis: A comprehensive drug target for solid malignancies.

Semin Cancer Biol 2017 08 21;45:13-22. Epub 2017 Jun 21.

Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, 145 Studely Rd, Heidelberg VIC, 3084, Australia.

View Article and Find Full Text PDF
August 2017

Generation of an inducible mouse model to reversibly silence Stat3.

Genesis 2017 04 23;55(4). Epub 2017 Feb 23.

Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, 3084, Australia.

View Article and Find Full Text PDF
April 2017

Inducible gene modification in the gastric epithelium of Tff1-CreERT2, Tff2-rtTA, Tff3-luc mice.

Genesis 2016 Dec 25;54(12):626-635. Epub 2016 Oct 25.

Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine La Trobe University, Heidelberg, Australia.

View Article and Find Full Text PDF
December 2016

Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.

Structure 2016 09 18;24(9):1550-61. Epub 2016 Aug 18.

The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia. Electronic address:

View Article and Find Full Text PDF
September 2016

Glycoprotein A33 deficiency: a new mouse model of impaired intestinal epithelial barrier function and inflammatory disease.

Dis Model Mech 2015 Aug 8;8(8):805-15. Epub 2015 May 8.

The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia Department of Medical Biology, University of Melbourne, Parkville, Victoria 3052, Australia Ludwig Institute for Cancer Research, Melbourne-Parkville Branch, Parkville, Victoria 3050, Australia

View Article and Find Full Text PDF
August 2015

Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration.

Sci Signal 2014 Sep 30;7(345):ra92. Epub 2014 Sep 30.

Ludwig Institute for Cancer Research, Melbourne, Victoria 3052, Australia. Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3052, Australia. Department of Medical Biology, University of Melbourne, Melbourne, Victoria 3052, Australia.

View Article and Find Full Text PDF
September 2014

Therapeutic inhibition of Jak activity inhibits progression of gastrointestinal tumors in mice.

Mol Cancer Ther 2014 Feb 7;13(2):468-74. Epub 2014 Jan 7.

Corresponding Author: Matthias Ernst, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.

View Article and Find Full Text PDF
February 2014

Methods to examine tight junction physiology in cancer stem cells: TEER, paracellular permeability, and dilution potential measurements.

Stem Cell Rev Rep 2012 Sep;8(3):1030-4

Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Australia.

View Article and Find Full Text PDF
September 2012

Symplekin promotes tumorigenicity by up-regulating claudin-2 expression.

Proc Natl Acad Sci U S A 2010 Feb 25;107(6):2628-33. Epub 2010 Jan 25.

Institut de Génomique Fonctionnelle, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut National de la Santé et de la Recherche Médicale U661, and Université Montpellier 1 and 2, Montpellier F-34094, France.

View Article and Find Full Text PDF
February 2010

AF6/s-afadin is a dual residency protein and localizes to a novel subnuclear compartment.

J Cell Physiol 2007 Jan;210(1):212-23

Department of Surgery, University of Melbourne, Clinical Sciences Building, Royal Melbourne Hospital, Parkville, VIC, Australia.

View Article and Find Full Text PDF
January 2007

DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.

Carcinogenesis 2007 Feb 8;28(2):246-58. Epub 2006 Jul 8.

CNRS UMR5203, INSERM U661, Université Montpellier I, and Service d'Anatomo-pathologie, CHU Groupe Hospitalisation Carémeau, Nîmes, France.

View Article and Find Full Text PDF
February 2007

Eve-3: a liver enriched suppressor of Ras/MAPK signaling.

J Hepatol 2006 Apr 12;44(4):758-67. Epub 2005 Dec 12.

Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Clinical Sciences Building, Parkville, Vic. 3050, Australia.

View Article and Find Full Text PDF
April 2006